Multiple studies support NF-κB-mediated chemotherapy resistance
- User
Multiple studies support NF-κB-mediated chemotherapy resistance
- Assistant
Multiple studies have demonstrated that NF-κB, a protein complex acting as a transcription factor, plays a significant role in mediating chemotherapy resistance in cancer cells. One key mechanism involves the activation of the MDR1 gene, which encodes P-glycoprotein, a transporter protein that expels chemotherapeutic agents from cells, thereby reducing their efficacy. In colorectal cancer cells, inhibition of NF-κB or MDR1 has been shown to increase apoptosis in response to chemotherapy, highlighting the role of NF-κB in promoting drug resistance[1].
Additionally, NF-κB activation has been linked to the upregulation of P-glycoprotein in kidney proximal tubule cells, providing protection against apoptosis induced by cadmium and reactive oxygen species[1]. These findings underscore the critical role of NF-κB in modulating chemotherapy resistance through the regulation of genes like MDR1.
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.